Skip to content

Sonu Real-World Use Clinical Study to Treat Moderate to Severe Nasal Congestion

Sonu Real-World Use Clinical Study to Treat Moderate to Severe Nasal Congestion

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06024564
Enrollment
121
Registered
2023-09-06
Start date
2023-08-08
Completion date
2024-08-31
Last updated
2025-01-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nasal Congestion

Brief summary

Real world utilization of Acoustic Resonance Therapy for symptoms of Nasal Congestion

Detailed description

This is an interventional study designed to gather data on real world utilization of Acoustic Resonance Therapy for treating moderate to severe nasal congestion

Interventions

DEVICESonu Acoustic Resonance Therapy

Participants will receive Sonu treatment twice a day for 90 days

Sponsors

Third Wave Therapeutics
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years of age and older * Present with symptoms of chronic nasal congestion * Have a 24 hour reflective nasal congestion subscore of the TNSS of 2 or more on a 0 to 3 scale at the time of screening

Exclusion criteria

* Head, nasal or sinus surgery within 3 months * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Weekly Utilization-Frequency90 daysWeekly utilization of Sonu treatment, measured as the frequency or number of times used per week
Weekly Utilization-Duration90 daysWeekly utilization of Sonu treatment, measured as the duration of treatment received per week

Secondary

MeasureTime frameDescription
Total Nasal Symptom Score (TNSS)90 days24-hour TNSS; Minimum score=0 (no symptoms), Maximum score=12 (severe symptoms). Lower scores are better and reflect less symptoms.
Asthma Control90 daysAsthma Control Test (ACT) Score; Minimum score = 5 (poor control of asthma). Maximum score = 25 (complete control of asthma). Higher scores reflect greater asthma control.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026